For the latest media releases and news about Pharmaxis Ltd, please select from the following articles. Material news announcements made by Pharmaxis are first filed with the Australian Securities Exchange (ASX) and are also available on the ASX website.

11th Mar 10

Pharmaxis Completes Phase II clinical study with ASM8 in asthma patients

Pharmaxis Ltd today announced the successful completion of a Phase IIa dose profiling study with its new anti-inflammatory agent ASM8 in patients with allergic asthma.


Read full media release - pdf